330 related articles for article (PubMed ID: 29412489)
1. Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.
Carter LM; Poty S; Sharma SK; Lewis JS
J Labelled Comp Radiopharm; 2018 Jul; 61(9):611-635. PubMed ID: 29412489
[TBL] [Abstract][Full Text] [Related]
2. Tailoring antibodies for radionuclide delivery.
Kenanova V; Wu AM
Expert Opin Drug Deliv; 2006 Jan; 3(1):53-70. PubMed ID: 16370940
[TBL] [Abstract][Full Text] [Related]
3. Endoradiotherapy in cancer treatment--basic concepts and future trends.
Zoller F; Eisenhut M; Haberkorn U; Mier W
Eur J Pharmacol; 2009 Dec; 625(1-3):55-62. PubMed ID: 19836381
[TBL] [Abstract][Full Text] [Related]
4. Novel radioimmunopharmaceuticals for cancer imaging and therapy.
Sharkey RM; Goldenberg DM
Curr Opin Investig Drugs; 2008 Dec; 9(12):1302-16. PubMed ID: 19037837
[TBL] [Abstract][Full Text] [Related]
5. Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy.
Sharkey RM; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
Semin Nucl Med; 2010 May; 40(3):190-203. PubMed ID: 20350628
[TBL] [Abstract][Full Text] [Related]
6. Copper-67 as a therapeutic nuclide for radioimmunotherapy.
Novak-Hofer I; Schubiger PA
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):821-30. PubMed ID: 12029558
[TBL] [Abstract][Full Text] [Related]
7. Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy.
Rondon A; Degoul F
Bioconjug Chem; 2020 Feb; 31(2):159-173. PubMed ID: 31855602
[TBL] [Abstract][Full Text] [Related]
8. Prospects for enhancement of targeted radionuclide therapy of cancer using ultrasound.
Browning RJ; Rajkumar V; Pedley RB; Eckersley RJ; Blower PJ
J Labelled Comp Radiopharm; 2014 Apr; 57(4):279-84. PubMed ID: 24347456
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
Karagiannis TC
Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582
[TBL] [Abstract][Full Text] [Related]
10. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
Lindegren S; Frost SH
Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
[TBL] [Abstract][Full Text] [Related]
11. Combined molecular targeting for cancer therapy: a new paradigm in need of molecular imaging.
DeNardo SJ
J Nucl Med; 2006 Jan; 47(1):4-5. PubMed ID: 16391180
[No Abstract] [Full Text] [Related]
12. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
13. Antibody-based radiopharmaceuticals for imaging and therapy.
Holland JP
J Labelled Comp Radiopharm; 2018 Jul; 61(9):610. PubMed ID: 29771470
[No Abstract] [Full Text] [Related]
14. Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies.
Karagiannis TC
Hell J Nucl Med; 2007; 10(3):155-9. PubMed ID: 18084655
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.
Chauhan SC; Jain M; Moore ED; Wittel UA; Li J; Gwilt PR; Colcher D; Batra SK
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):264-73. PubMed ID: 15791435
[TBL] [Abstract][Full Text] [Related]
16. [Immunotargeting of tumors: state of the art and prospects in 2000].
Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I
Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287
[TBL] [Abstract][Full Text] [Related]
17. [Radioimmunotherapy: current state of the problem].
Chernov VI; Bragina OD; Sinilkin IG; Medvedeva AA; Zelchan RV
Vopr Onkol; 2016; 62(1):24-30. PubMed ID: 30444328
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoimaging and radioimmunotherapy: will these be routine procedures?
Bischof Delaloye A
Semin Nucl Med; 2000 Jul; 30(3):186-94. PubMed ID: 10928382
[TBL] [Abstract][Full Text] [Related]
19. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
20. Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology.
Knowles SM; Wu AM
J Clin Oncol; 2012 Nov; 30(31):3884-92. PubMed ID: 22987087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
